Sep 18, 2026 08:05AM
Sep 18, 2026 08:05AM
Sep 10, 2026 04:07PM
Sep 10, 2026 04:05PM
Jun 15, 2026 07:03AM
Jun 15, 2026 07:00AM
Sep 3, 2025 07:02AM XORTX begins IND preparation for gout treatment XORLO
Sep 3, 2025 07:00AM
Aug 7, 2025 07:02AM
Aug 7, 2025 07:00AM
Apr 30, 2025 07:02AM
Apr 30, 2025 07:00AM
Mar 19, 2025 07:02AM
Mar 19, 2025 07:00AM XORTX Announces Update for Discussion with the FDA
Feb 24, 2025 07:03AM
Feb 24, 2025 07:00AM
Jan 29, 2025 07:00AM
Jan 6, 2025 07:03AM
Jan 6, 2025 07:00AM
Mar 27, 2024 05:51AM
Mar 27, 2024 05:00AM XORTX Announces New Clinical Advisory Board Member
Mar 19, 2024 05:00AM
Aug 29, 2023 07:00AM
Aug 29, 2023 07:00AM
Jun 29, 2023 08:00AM
May 4, 2023 07:11AM
May 4, 2023 07:00AM
Apr 21, 2023 07:00AM XORTX Therapeutics Inc (XRTX) Receives FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease
Apr 21, 2023 07:00AM
Mar 14, 2023 07:05AM
Mar 14, 2023 07:00AM
Feb 22, 2023 06:11PM
Feb 22, 2023 04:32PM
Feb 7, 2023 07:00AM
Feb 1, 2023 07:03AM XORTX Therapeutics Inc (XRTX) Submits Orphan Drug Designation Request for XRx-008
Feb 1, 2023 07:00AM
Dec 19, 2022 07:00AM
Dec 8, 2022 07:00AM
Nov 28, 2022 07:00AM
Oct 26, 2022 07:06AM
Oct 26, 2022 07:00AM
Sep 19, 2022 07:00AM XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
Aug 4, 2022 07:01AM
Aug 4, 2022 07:00AM
Jul 19, 2022 07:01AM
Jul 19, 2022 07:00AM
Jul 7, 2022 07:03AM
Jul 7, 2022 07:00AM
Jun 6, 2022 07:00AM XORTX Welcomes New Member to the Board of Directors and Appoints Chair
May 5, 2022 07:07AM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All